Loading...
Ablynx NV

Ablynx NV (ABLX)

52.78
0 (0.00%)

About


Edwin Moses
Healthcare
Biotechnology
Nasdaq Global Select

Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.